You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國家醫保局:相當數量意見認為植牙總體費用應控制在一萬元人幣以內
國家醫保局微信號發文指,在8月下旬收集了232份口腔種植醫療服務收費和耗材價格專項治理的意見。整體來看,社會對口腔種植領域專項治理工作普遍持支持和肯定態度。 約60%的反饋意見支持開展專項治理。群眾對口腔種植領域「天價收費」、宣傳虛假補貼、用低價廣告欺騙患者、用「好處費」「介紹費」買賣客源等問題反映強烈,呼籲口腔種植專項治理方案盡快落地。不少醫生、企業從業人員也留言表示支持,認為「種植牙領域亂象叢生,此次治理方案抓到了重點」「口腔收費貴現象,確實存在,很期待這次的改革」。 約30%的反饋意見在表達支持的同時提出建設性意見。此類反饋意見關注度最高的是全流程價格調控的具體目標。相當數量的反饋意見認為,種植牙的手術價格和耗材費用總體應控制在一萬元人民幣(下同)以內,構成上要能夠充分體現種植體植入、牙冠置入等技術勞務服務的主體地位。 部分意見認為,價格治理調控目標不宜一刀切,應考慮地區差異等因素允許浮動,促進行業可持續發展。也有部分意見強調降價力度,希望總體降至3,000元左右。 約10%的反饋意見表達了反對或保留態度。有的認為醫院收費高是合理的,例如「種植牙手術難度大,要充分考慮醫務人員承擔的風險與付出,體現醫生技術勞務價值等。有的認為口腔種植屬於消費型改善型服務,政府不應干預市場價格,「民營機構自負盈虧,當前價格也是市場充分競爭結果,政府管好公立醫療機構就可以」。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account